✦ LIBER ✦

Significance of chromosomal alterations and mutations of the N-RAS and TP53 genes in relation to leukemogenesis of acute myeloid leukemia

✍ Scribed by Shinichi Misawa; Shigeo Horiike; Hiroto Kaneko; Yuri Sasai; Yutaka Ueda; Makoto Nakao; Shouhei Yokota; Masafumi Taniwaki; Hiroshi Fujii; Hitoshi Nakagawa; Shouichirou Tsuda; Kei Kashima

Book ID: 114119466
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 97 KB
Volume: 22
Category: Article
ISSN: 0145-2126
DOI: 10.1016/s0145-2126(98)00056-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FLT3, RAS, and TP53 mutations in elderly

FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia

✍ Stirewalt, D. L. 📂 Article 📅 2001 🏛 American Society of Hematology 🌐 English ⚖ 506 KB

Prognostic value of TP53 gene mutations

Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine

✍ Bally, Cecile; Adès, Lionel; Renneville, Aline; Sebert, Marie; Eclache, Virginie 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 565 KB

RAS, FLT3, and TP53 mutations in therapy

RAS, FLT3, and TP53 mutations in therapy-related myeloid malignancies with abnormalities of chromosomes 5 and 7

✍ Lucy E. Side; Nicole P. Curtiss; Kathryn Teel; Christian Kratz; Pauline W. Wang; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

## Abstract Oncogenic mutations in the __KRAS2__, __NRAS__, or __FLT3__ gene are detected in more than 50% of patients with de novo acute myeloid leukemia (AML). __RAS__ mutations are also prevalent in de novo myelodysplastic syndrome (MDS), especially chronic myelomonocytic leukemia and juvenile m

Mutations of the RAS genes in childhood

Mutations of the RAS genes in childhood acute myeloid leukemia, myelodysplastic syndrome and juvenile chronic myelocytic leukemia

✍ Xiao Ming Sheng; Machiko Kawamura; Hiroaki Ohnishi; Kohmei Ida; Ryoji Hanada; Se 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 609 KB

Overview of available p53 function tests

Overview of available p53 function tests in relation to TP53 and ATM gene alterations and chemoresistance in chronic lymphocytic leukemia

✍ te Raa, G. Doreen; Malcikova, Jitka; Pospisilova, Sarka; Trbusek, Martin; Mraz, 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 648 KB

P-112 Response to azacitidine is indepen

P-112 Response to azacitidine is independent of TP53 mutations in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemia

✍ Mueller-Thomas, C.; Rudelius, M.; Wolf, P.; Schanz, J.; Schmidt, B.; Platzbecker 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 206 KB